Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil

References

• Agarwal, A., Asthana, A., Gupta, U., Jain, N.K. (2008b). Tumour and dendrimers: a review on drug delivery aspects. JPP. 60:671–88.
   Google Scholar
• Agarwal, A., Gupta, U., Asthana, A., Jain, N.K. (2009). Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials. 30:3588–96.
   PubMed Web of Science ®Google Scholar
• Agarwal, A., Saraf, S., Asthana, A., Gupta, U., Gajbhiye, V., Jain, N.K. (2008a). Ligand based dendritic sytems for tumor targeting. Int J Pharm. 350:3–13.
   PubMed Web of Science ®Google Scholar
• Anghileri, L.J. (1976). In vivo synthesis of acid mucopolysaccharides by Ehrlich ascites tumor cells. J Cancer Res Clin Oncol. 88:17–24.
   Google Scholar
• Aranda, E., Diaz-Rubio, E., Cervantes, A., Anton-Torres, A., Carrato, A., Massuti, T., Tabernero, J.M., Sastre, J., Tres, A., Aparicio, J., Lopez-Vega, J.M., Barneto, I., Garcia-Conde, J. (1998). Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study. Ann Oncol. 9:727–31.
   PubMed Web of Science ®Google Scholar
• Asplund, T., Heldin, P. (1994). Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res. 54:4516–23.
   PubMed Web of Science ®Google Scholar
• Bhadra, D., Bhadra, S., Jain, S., Jain, N.K. (2003). PEGylated dendritic nanoparticulate carrier of fluorouracil. Int J Pharm. 257:111–24.
   PubMed Web of Science ®Google Scholar
• Cho, H., Chung, D., Jeongho, A. (2004). Poly(D,L-lactide-ran-ϵ-caprolactone)-poly (ethylene glycol)-poly(D,L-lactide-ran-ϵ-caprolactone) as parenteral drug-delivery systems. Biomaterials. 25:3733–42.
   PubMed Web of Science ®Google Scholar
• Culty, M., Nguyen, H.A., Underhillm, C.B. (1992). The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol. 116:1055–62.
   PubMed Web of Science ®Google Scholar
• Diasio, R.B., Lu, Z. (1994). Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy. J Clin Oncol. 12:2239–42.
   PubMed Web of Science ®Google Scholar
• Dubernet, C. (1995). Thermoanalysis of microspheres. Thermochim Acta. 248:259–69.
   Web of Science ®Google Scholar
• Gamelin, E.C., Danquechin-Dorval, E.M., Dumesnil, Y.F., Maillart, P.J., Goudier, M.J., Burtin, P.C., Delva, R.G., Lortholary, A.H., Gesta, P.H., Larra, F.G. (1996). Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU. Cancer 77:441–51.
   PubMed Web of Science ®Google Scholar
• Gref, R., Couvreur, P., Barratt, G., Mysiakine, E. (2003). Surface-engineered nanoparticles for multiple ligand coupling. Biomaterials. 24:4529–37.
   PubMed Web of Science ®Google Scholar
• Hans, M., Shimoni, K., Danino, D., Siegel, S.J., Lowman, A. (2005). Synthesis and characterization of mPEG-PLA prodrug micelles. Biomacromolecules. 6:2708–17.
   PubMed Web of Science ®Google Scholar
• He, Y.C., Chen, J.W., Cao, J., Pan, D.Y., Qiao, J.G. (2003). Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats. World J Gastroenterol. 9:1795–98.
   PubMed Web of Science ®Google Scholar
• Iba, T., Yagi, Y., Kidokoro, A., Fukunaga, M., Momose, F., Nagakari, K. (1997). Intermittent low-dose cisplatin infusion as a possible modulator of 5-fluorouracil. Int J Clin Oncol. 2:197–201.
   Google Scholar
• Jeon, H., Jeong, Y., Jang, M., Park, Y., Nah, J. (2000). Effect of solvent on the preparation of surfactant-free poly (D,L-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. Int J Pharm. 207:99–108.
   PubMed Web of Science ®Google Scholar
• Lee, J.S., Chae, G.S., An, T.K., Khang, G. (2003). Preparation of 5-fluorouracil-loaded poly(L-lactide-co-glycolide) wafer and evaluation of in vitro release behavior. Macromol Res. 11:183–88.
   Web of Science ®Google Scholar
• Lesley, J., Hascall, V.C., Tammi, M., Hyman, R. (2000). Hyaluronan binding by cell surface CD44. J Biol Chem. 275:26967–75.
   PubMed Web of Science ®Google Scholar
• Li, Y.P., Ogris, M., Wagner, E., Pelisek, J., Ruffer, M. (2003). Nanoparticles bearing polyethylene glycol-coupled transferrin as gene carriers: preparation and in vitro evaluation. Int J Pharm. 259:93–101.
   PubMed Web of Science ®Google Scholar
• Love, W.G., Amos, N., Williams, B.D., Kellaway, I.W. (1989). Effect of liposome surface charge on the stability of technetium (99mTc) radiolabelled liposomes. J Microencap. 6:105–13.
   PubMed Web of Science ®Google Scholar
• Luo, Y., Kirker, K.R., Prestwich, G.D. (2000). Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J Control Rel. 69:169–84.
   PubMed Web of Science ®Google Scholar
• Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J.W., Meijer, E.W., Paulus, W., Duncan, R. (2000). Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Contr Rel. 65:133–48.
   PubMed Web of Science ®Google Scholar
• Miglietta, A., Cavalli, R., Bocca, C., Gabriel, L., Gasco, M.R. (2000). Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. Int J Pharm. 210:61–7
   PubMed Web of Science ®Google Scholar
• Mo, Y., Lim, L.Y. (2005). Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J Control Rel 108:244–62.
   PubMed Web of Science ®Google Scholar
• Mohanraj, V.J., Chen, Y. (2006). Nanoparticles–a review. TJPR. 5:561–73.
   Google Scholar
• Mu, L., Feng, S.S. (2002). Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel. J Contr Rel. 80:129–44.
   PubMed Web of Science ®Google Scholar
• Naor, D., Nedvetzki, S., Golan, I., Melnik, L., Faitelson, Y. (2002). CD44 in cancer. Crit Rev Clin Lab Sci, 39:527–79.
   PubMed Web of Science ®Google Scholar
• Nasongkla, N., Shuai, X., Ai, H., Weinberg, B.D., Pink, J., Boothman, D.A., Gao, J. (2004). cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed. 43:6323–27.
   PubMed Web of Science ®Google Scholar
• Panyam, J., Labhasetwar, V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 55:329–47.
   PubMed Web of Science ®Google Scholar
• Park, E.K., Lee, S.B., Lee, Y.M. (2005). Preparation and characterization of methoxy poly- (ethylene glycol)/poly (ϵ-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials. 26:1053–61.
   PubMed Web of Science ®Google Scholar
• Peer, D., Margalit, R. (2004). Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models. Neoplasia. 6:343–53.
   PubMed Web of Science ®Google Scholar
• Peracchia, M.T., Gref, R., Minamitake, Y., Domb, A., Lotan, N., Langer, R. (1997). PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulation and release characteristics. J Control Release. 46:223–31.
   Web of Science ®Google Scholar
• Perez, C., Sanchez, A., Putnam, D., Ting, D., Langer, R., Alonso, M.J. (2001). Poly(lactic acid)–poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Contr Rel. 75:211–24.
   PubMed Web of Science ®Google Scholar
• Ratnam, M., Hao, H., Zheng, X., Wang, H., Qi, H., Lee, R., Pan, X. (2003). Receptor induction and targeted drug delivery: a new antileukemia strategy. Expert Opin Biol Ther. 3:563–74.
   PubMed Web of Science ®Google Scholar
• Reddy, J.A., Dean, D., Kennedy, M.D., Low, P.S. (1999). Optimization of folate conjugated liposomal vectors for folate receptor-mediated gene therapy. J Pharm Sci. 88:1112–8.
   PubMed Web of Science ®Google Scholar
• Richardson, V.J., Jeyasingh, K., Jewkes, R.F. (1977). Properties of [99mTc] technetium-labeled liposomes in normal and tumour-bearing rats. Biochem Soc Trans. 5:220–9.
   Google Scholar
• Schilsky, R.L., Hohneker, J., Ratain, M.J., Janisch, L., Smetzer, L., Lucas, V.S., Khor, S.P., Diasio, R., Von Hoff, D.D., Burris, H.A. (1998). 3rd Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer. J Clin Oncol. 16:1450–7.
   PubMed Web of Science ®Google Scholar
• Shenoy, D., Little, S., Langer, R., Amiji, M. (2005). Poly (ethylene oxide)-modified poly (β-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies. Pharm Res. 22:2101–14.
   Google Scholar
• Shenoy, D.B., Amiji, M.M. (2005). Poly (ethylene oxide)-modified poly (epsilon caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm. 293:261–70.
   PubMed Web of Science ®Google Scholar
• Shirasaka, T., Yamamitsu, S., Tsuji, A., Terashima, M., Hirata, K. (2000). Conceptual changes in cancer chemotherapy–biochemical modulation of 5-FU. Gan To Kagaku Ryoho. 27:832–45.
   PubMedGoogle Scholar
• Shuai, X., Ai, H., Nasongkla, N., Kim, S., Gao, J. (2004). Micellar carriers based on block copolymers of poly (ϵ-caprolactone) and poly (ethylene glycol) for doxorubicin delivery. J Control Rel. 98:415–26.
   PubMed Web of Science ®Google Scholar
• Singhai, A.K., Jain, S., Jain, N.K. (1997). Evaluation of aqueous suspension of ketoprofen. Pharmazie. 52:149–51.
   PubMed Web of Science ®Google Scholar
• Swayam, P., Labhasetwar, V. (2004). Critical determinants in PLGA/PLA nanoparticles-mediated gene expression. Pharm Res. 21:354–64.
   PubMed Web of Science ®Google Scholar
• Wang, C., Thor, A.D., Moore, D.H., Zhao, Y., Kerschmann, R., Stern, R., Watson, P.H., Turley, E.A. (1998). The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signalling, correlates with over-expression of mitogenactivated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res. 4:567–76.
   PubMed Web of Science ®Google Scholar
• Xu, Z., Gu, W., Huang, J., Sui, H., Zhou, Z., Yang, Y., Yan, Z., Li, Y. (2005). In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int J Pharm. 288:361–8.
   PubMed Web of Science ®Google Scholar
• Yadav, A.K., Mishra, P., Mishra, A.K., Mishra, P., Jain, S., Agrawal, G.P. (2007). Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomed Nanotechnol Biol Med. 3:246–57.
   PubMed Web of Science ®Google Scholar
• Yuan Li, W.G., Li, Z.S., Zhang, S.H., Sun, Y.J., Hu, P.Z., Wang, X.M., Huang, Y., Si, S.Y., Zhang, X.M., Sui, Y.F. (2009). The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route. Cancer Immunol Immunother. 58:201–8.
   PubMed Web of Science ®Google Scholar
• Yun, Y.H., Goetz, D.J., Yellen, P., Chen, W. (2004). Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials. 25:147–57.
   PubMed Web of Science ®Google Scholar
• Zalipsky, S., Gilon, C., Zilkha, A. (1983). Attachment of drugs to polyethylene glycols. Eur Polym J. 19:1177–83.
   Web of Science ®Google Scholar
• Zambaux, M.F., Bonneaux, F., Gref, R., Dellacherie, E., Vigneron, C. (2001). Protein C-loaded monomethoxypoly(ethylene oxide)–poly(lactic acid) nanoparticles. Int J Pharm. 212:1–9.
   PubMed Web of Science ®Google Scholar
• Zeng, C., Toole, B.P., Kinney, S.D., Kuo, J.W., Stamenkovic, I. (1998). Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer. 77:396–401.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Guo, L., Roeske, R.W., Antony, A.C., Jayaram, H.N. (2004). Pteroyl-γ-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes. Anal Biochem. 332:168–77.
   PubMed Web of Science ®Google Scholar